Skip to main content
Erschienen in: BMC Public Health 1/2024

Open Access 01.12.2024 | Research

Composite dietary antioxidant index and sleep health: a new insight from cross-sectional study

verfasst von: Bingquan Xiong, Jiaxin Wang, Rui He, Guangsu Qu

Erschienen in: BMC Public Health | Ausgabe 1/2024

Abstract

Background

Low-quality sleep and obstructive sleep apnea (OSA) can result in series of chronic diseases. Healthy diet has been considered as an effective and simple strategy to optimize sleep quality. However, current evidence on the correlation of dietary composite antioxidant intake with sleep health remained obscure.

Aim of the study

To determine the relationship of composite dietary antioxidant index (CDAI) and sleep health.

Methods

Cross-sectional analyses were based on National Health and Nutrition Examination Survey (NHANES) 2005–2008. Dietary consumption was assessed by trained staff using 24-h diet recall method and CDAI was calculated based on previous validated approach that included six antioxidants. Sleep-related outcomes were self-reported by a set of questionnaires and classified into OSA, day sleepiness, and insufficient sleep. Weighted logistic regression was conducted to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Restricted cubic spline (RCS) regressions were also used to evaluate the dose-response of CDAI and three sleep-related outcomes.

Results

A total of 7274 subjects included (mean age: 46.97 years) were enrolled in our study, including 3658 were females (52.54%) and 3616 were males (47.46%). Of them, 70.6%, 29.51%, and 35.57% of the subjects reported that they had OSA, day sleepiness and insufficient sleep, respectively. Logistic regression showed the highest quartile of CDAI was inversely associated with the risk of OSA (OR: 0.69, 95%CI: 0.49–0.97), day sleepiness (OR: 0.64, 95%CI: 0.44–0.94) and insufficient sleep (OR: 0.68, 95%CI: 0.50–0.92) compared with the lowest quartile. RCS showed linear relationship of CDAI and insufficient sleep but non-linear relationship of CDAI with OSA and day sleepiness.

Conclusions

Our results show that CDAI was non-linearly associated with lower risk of OSA and day sleepiness whereas a linear inverse association between CDAI and insufficient sleep was observed. These findings implicate that combined intake of antioxidants could be a promising and effective approach to optimize sleep quality for public.
Hinweise
Bingquan Xiong and Jiaxin Wang contributed equally to this work and share first authorship

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Over the past decades, sleep disorders have been confirmed a common concern that affected 50–70 million U.S. population [1] and brought serious threat to public health worldwide. Low-quality sleep including obstructive sleep apnea (OSA) and insufficient sleep was highly related to a series of adverse outcomes, including cancer, diabetes, metabolic syndrome and cardiovascular diseases [2]. Although continuous positive airway pressure (CPAP), reducing excessive drowsiness and improve patients’ quality of life, is the recommendable and standard treatment for OSA [3], the adherence rate of CPAP is only ranging from 30 to 60%, which significantly affects the therapeutic outcomes of OSA patients [4]. Therefore, effective early prevention, including the development of a healthy lifestyle and diet, is currently an urgent need for the prevention of sleep disorders.
The imbalance of prooxidants and antioxidants of diet could contribute to sleep disorders [58]. However, little epidemiological evidence has focused on the total antioxidant property of diet in the pathogenesis of sleep disorders. A possible explanation was that researchers did not take into account the potential interaction and synergistic effects between different antioxidants [9]. In fact, literatures of individual antioxidant nutrient on OSA are scarce and the results are not consistent. More importantly, a previous meta-analysis concluded that an increase in antioxidant supplement was not always beneficial and sometimes acted as cocarcinogen to increase mortality [10]. Conversely, intake of nutrients from foods and beverages might bring more positive influence on our body because they were rich in flavones, dietary fiber, phenolic compounds, folic acid and other antioxidants. Recently, composite dietary antioxidant index (CDAI), consisted of vitamin A, C, E, selenium, zinc and carotenoids, has been considered as a comprehensive and promising index to assess the cumulative effect of total dietary antioxidant capacity (DTAC). However, previous studies investigating the relationship between sleep disorders and DTAC mostly had limited study simple size and focused on specific population, such as diabetic women [11] and post-menopausal women [12].
To our knowledge, no large-scale investigations have explored whether DTAC could reduce the risk of OSA and other sleep disorders among overall population. To fill in these knowledge gaps, we obtained public data from the National Health and Nutrition Examination Survey (NHANES) to assess the effect of CDAI on sleep disorders among Americans, including OSA, day sleepiness and insufficient sleep.

Methods

Study design

The NHANES, a periodic and nationally program with a series of multistage stratified sample design, conducted by the National Center for Health Statistics (NCHS) to survey the nutritional and health status of US adults [13]. The NCHS signed all informed consent which was obtained from each participants at the time of recruitment [14]. Detailed information regarding the survey design, codebooks, and methodologies employed in NHANES can be accessed on the official NHANES website: https://​www.​cdc.​gov/​nchs/​nhanes/​index.​htm.
The current research analyzed data focused on the NHANES 2005–2006 and 2007–2008 cycles. Specifically, a total of 20,497 individuals from these two continuous cycles were surveyed in current investigation. Among them, we excluded those without available CDAI data (n = 4529), those without sleep interview (n = 5842), those who had missing information on potential covariates (n = 2778) and further excluded those who had implausible daily energy intake (< 500 kcal per day or > 5000 kcal per day, n = 74). Finally, 7274 subjects with complete data were enrolled in our statistical analysis. Figure 1 shows the participants selection flowchart.
A set of complete questionnaires about sleep were publicly provided in NHANES 2005–2008. These questionnaires were consistent with Sleep Heart Health Study. Additionally, the Computer-Assisted Personal Interview (CAPI) was equipped with built-in consistency verification to reduce data entry errors when the trained collected the information about sleep [15]. According to our definition, we choose three self-reported outcomes related to sleep quality in our study. Detailed information about the sleep-related health definition was described as follows.
Sleep duration: In NHANES 2005–2008, sleep duration was determined by the interview “How much sleep do you get(hours)?” and responses were recorded as hours. According to previous literature [16], sleep duration was grouped into insufficient sleep (< 7 h/night), mid-range sleep (7-9 h/night) and excessive sleep (> 9 h/night) [16, 17].
OSA: The diagnosis of OSA was based on one or more of the following four conditions:1) Snoring 3 or more nights/week; 2) snorting, gasping, or stopping breathing 3 or more nights/week; 3) feeling excessively sleepy during the day 16–30 times/month despite sleeping around 7 or more hours/night on weekdays or work nights; or 4) doctor diagnosed sleep apnea [18].
Day sleepiness: In our selective NHANES cycles, day sleepiness was evaluated by following 2 questions that asked, “In the past month, how often did you feel unrested during the day, no matter how many hours of sleep you had?” Another question was “In the past month, how often did you feel excessively or overly sleepy during the day?” The response classifications were “Never”, “Rarely (1 time per month)”, “Sometimes (2–4 times per month)”, “Often (5–15 times per month)” and “Almost always (16–30 times per month)”. Subjects who answered “Often” and “Almost always” were regarded as having day sleepiness [18].

Composite dietary antioxidant index assessment

The information on dietary and their components was collected by highly trained staffs in NHANES. All participants had two 24-h dietary recall surveys. All NHANES examinees were eligible to take part in these recall interviews. The first 24-hour recall record was determined face-to-face by trained food recall data collectors, then the second was performed over the phone 3–10 days later [19]. In current research, information about dietary intake data were complete for all participants. Hence, the average antioxidant intake over 2 days was used in final statistical analysis to reduce bias. The calculation of CDAI was based on six kinds of antioxidant components, including vitamin A, vitamin C, vitamin E, zinc, selenium, and carotenoids. Specifically, each antioxidant was standardized by subtracting the total mean and dividing the total standard deviation. Next, we summed the standardized intake of individual nutrient to obtain the CDAI according to the equation reported in previous study [20].

Covariates

According to prior studies and clinical experience, we considered appropriate covariates that associated with sleep quality. Information about age, gender, race, education, marital status, poverty income ratio (PIR) was collected from demographic questionnaires. Obesity was defined as BMI ≥ 30Kg/m2. In current study, the diagnosis of hypertension was based on one or more of the following three conditions: (1) Participants answered the blood pressure questionnaire “Has a doctor or other health professional ever told you that you had hypertension?” (2) Participants were regarded as hypertensive if the average systolic blood pressure (SBP) was ≥ 140mmHg or the average diastolic blood pressure (DBP) ≥ 90mmHg. (3) If individuals currently taken any antihypertensive drug, they were also considered as hypertension. Based on prior literature’s definition of alcohol consumption, we categorized these individuals into following four groups:1) Never drinking: no history of alcohol consumption, 2) Current heavy drinking [≥ 3 drinks/day for women, ≥ 4 drinks/day for men, or binge 5 drinks/day or more], 3)current moderate drinking [≥ 2 drinks/day for women, ≥ 3 drinks/day for men, or binge ≥ 2 days/month], 4)current light drinking [≤ 1 drinks/day for women, ≤ 2 drinks/day for men, or had a history of binge drinking] [21]. Diabetes was defined as the definite diagnosis told by doctors or current use of diabetes medications or insulin.

Statistical analysis

In current analysis, all statistical tests were bilateral, and p < 0.050 was defined as statistical significance. All missing values were excluded and R software was conducted for data analysis. To account for the complexity of sampling design in NHANES 2005–2006 and 2007–2008, the 2-year sample weights were applied in our final analysis according to the stipulated analytical guidelines [22]. Continuous variables are displayed as mean ± standard error (SE) and categories variables are indicated as frequency with percentage. In order to compare the difference among baseline characteristics by CDAI quartile groups, we used one-way ANOVA tests for continuous variables and chi-square tests for categorical variables. The intakes of dietary factors were further adjusted for total energy intake using the residual method [23]. A series of logistic regressions were built to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) between CDAI and different sleep-related outcomes after adjusting confounding factors. Model 1 was a crude model. Model 2 adjusted for age, gender, race and marital status. Model 3 was additionally adjusted all covariates in model 2 plus education level, PIR, smoke status, alcohol status, cardiovascular disease (CVD), hypertension, diabetes and daily intake of energy, caffeine, carbohydrate, fat, protein, and fiber. Additionally, we performed CDAI as a continuous variable in these logistic models. Of note, we also examined the ORs (95% CIs) per 1-standard deviation (SD) increase in different models. The risk of sleep-related outcomes and daily intake of individual antioxidant were also evaluated in the fully-adjusted model. The linear trend was conducted by assigning CDAI quartiles as an ordinal variable in these models. To further visualize relationship between CDAI and each sleep-related outcome, restricted cubic spline (RCS) was also conducted in our analysis. Finally, subgroup analyses were used to investigate the correlation between CDAI and each sleep-related outcome in different population. Likelihood ratio test was conducted to calculate interaction among these subgroups.

Results

Baseline characteristics of participants

The sample size from NHANES 2005–2008 was 7274, representing a total population-based size of 96,752,239 females and 87,400,859 males in the United States. Characteristics of subjects according to CDAI quartiles (Q1: CDAI ≤-2.30; Q2: -2.30 < CDAI≤-0.19; Q3: -0.19 < CDAI ≤ 2.49; Q4: CDAI > 2.49) are illustrated in Table 1. Of the 7274 participants (mean age: 46.97 ± 0.47 years), 3616 (47.46%) were males and 3658 (52.54%) were females in this analysis. In addition, most participants were overweight with the mean BMI of the subjects was approximately 28.70Kg/m2. In addition, approximately 70.06%, 29.51%, and 35.57% of the participants reported that they had OSA, day sleepiness and insufficient sleep, respectively. Compared with the lowest quartile (Q1), the subjects in the highest CDAI quartile (Q4) were more likely to be younger adults, male, married, mild alcoholics, non-Hispanic White, college-educated, have higher intake of energy, carbohydrate, fat, protein, fiber, and caffeine, and have a PIR > 3.50 while were less prone to be smokers and have lower prevalence of diabetes and CVD (all p < 0.050). No significant difference was observed among four CDAI categories on hypertension and BMI (all p > 0.050).
Table 1
Characteristics of participants stratified by the CDAI, weighted (n = 7274)a
Variables
Total(n = 7274)
Q1(n = 1823)
Q2(n = 1815)
Q3(n = 1817)
Q4(n = 1819)
P
Age,years
46.97 ± 0.47
47.12 ± 0.48
48.01 ± 0.66
46.86 ± 0.72
46.09 ± 0.62
0.035
BMI,kg/m2
28.70 ± 0.19
28.75 ± 0.26
28.92 ± 0.18
28.71 ± 0.28
28.46 ± 0.30
0.328
Energy,kcal/d
2093.55 ± 18.58
1447.62 ± 24.14
1871.36 ± 21.21
2215.35 ± 18.65
2657.78 ± 24.75
< 0.001
Carbohydrate,g/day
252.80 ± 2.16
181.14 ± 3.69
226.99 ± 2.76
266.53 ± 3.26
316.12 ± 2.22
< 0.001
Fat,g/day
79.79 ± 0.95
52.95 ± 0.93
70.74 ± 0.86
85.26 ± 1.09
102.72 ± 1.45
< 0.001
Protein,g/day
82.53 ± 0.82
52.06 ± 0.87
72.62 ± 0.77
86.91 ± 0.71
109.94 ± 1.49
< 0.001
Fiber,g/day
15.99 ± 0.28
9.26 ± 0.18
13.44 ± 0.18
16.77 ± 0.19
22.49 ± 0.39
< 0.001
Caffeine,g/day
179.23 ± 4.88
183.59 ± 11.88
176.65 ± 7.39
174.23 ± 7.19
182.58 ± 7.79
0.887
Gender,n(%)
     
< 0.001
Female
3658(52.54)
1010(59.94)
909(52.75)
875(49.64)
864(49.35)
 
Male
3616(47.46)
813(40.06)
906(47.25)
942(50.36)
955(50.65)
 
Race,n(%)
     
0.001
Mexican American
1229(7.54)
336(8.17)
307(8.05)
309(8.03)
277(6.20)
 
Non-Hispanic Black
1523(10.61)
460(13.83)
388(11.61)
358(10.15)
317(7.74)
 
Non-Hispanic White
3775(73.58)
824(69.19)
927(71.41)
965(74.12)
1059(78.22)
 
Other races
747(8.27)
203(8.81)
193(8.93)
185(7.70)
166(7.83)
 
Education,n(%)
     
< 0.001
<High school
1965(17.30)
689(26.64)
513(17.71)
419(14.97)
344(11.96)
 
High school
1781(25.17)
497(30.37)
480(28.10)
410(23.76)
394(20.10)
 
>High school
3528(57.52)
637(42.98)
822(54.19)
988(61.27)
1081(67.95)
 
Marital status,n(%)
     
0.001
Unmarried
1075(16.52)
298(19.16)
261(16.53)
241(14.55)
275(16.30)
 
Married
4036(56.90)
919(50.06)
1002(56.11)
1078(60.14)
1037(59.82)
 
Others
2163(26.57)
606(30.78)
552(27.36)
498(25.30)
507(23.88)
 
PIR,n(%)
     
< 0.001
≤ 1.30
1950(18.16)
643(25.47)
515(20.78)
415(14.51)
377(13.77)
 
1.30–3.50
2867(36.00)
766(40.40)
732(37.26)
713(35.26)
656(32.29)
 
> 3.50
2457(45.83)
414(34.13)
568(41.96)
689(50.23)
786(53.93)
 
Hypertension,n(%)
3140(37.11)
873(39.90)
810(38.75)
745(35.63)
712(34.99)
0.149
Diabetes,n(%)
910(8.47)
264(8.67)
252(10.94)
208(8.06)
186(6.68)
0.005
Smoke,n(%)
1556(23.13)
527(34.36)
376(23.14)
356(21.09)
297(16.38)
< 0.001
CVD,n(%)
850(8.33)
278(11.46)
226(9.53)
190(8.01)
156(5.24)
< 0.001
Alcohol status,n(%)
     
< 0.001
Never
2564(28.43)
788(36.00)
682(30.73)
565(25.30)
529(23.63)
 
Mild
2300(34.68)
436(25.69)
555(32.07)
640(36.70)
669(41.86)
 
Moderate
1063(16.28)
255(14.59)
240(15.38)
275(17.65)
293(17.04)
 
Heavy
1347(20.61)
344(23.72)
338(21.82)
337(20.35)
328(17.47)
 
OSA,n(%)
5019(70.06)
1248(72.86)
1259(70.07)
1238(69.46)
1274(68.44)
0.184
Day sleepiness,n(%)
1953(29.51)
501(34.12)
461(27.85)
497(30.06)
494(26.85)
0.035
Insufficient Sleep,n(%)
2809(35.57)
770(40.63)
728(38.47)
684(34.94)
627(29.91)
< 0.001
Continuous variables were showed as mean ± SE,categorical variables were showed as frequency (percentage)
Q1:CDAI≤-2.30; Q2:-2.30 < CDAI≤-0.19; Q3:-0.19 < CDAI ≤ 2.49; Q4:CDAI > 2.49.
aAll estimates accounted for complex survey designs, and all percentages were weighted
Abbreviations:, quartile; SE, standard error; CDAI, composite dietary antioxidant index; BMI, body mass index; PIR, poverty income ratio; CVD, cardiovascular disease; OSA, Obstructive sleep apnea

Association between CDAI and sleep health

The associations between CDAI and three sleep-related outcomes are illustrated in Table 2. Compared with the lowest quartile (Q1), an inverse association between the highest quartile (Q4) and each sleep-related outcome was observed in fully-adjusted model. After adjusting all potential confounders, the OR (95%CI) comparing participants in Q4 vs. Q1 of CDAI was 0.69 (0.49, 0.97) for OSA, 0.64 (0.44, 0.94) for day sleepiness, and 0.68 (0.50, 0.92) for insufficient sleep (all p < 0.050). What’s more, we converted CDAI from a categorical exposure to a continuous exposure, a similar negative association was observed for CDAI with each sleep-related outcome in fully adjusted model (OSA: β = 0.98, 95%CI: 0.95-1.00; day sleepiness: β = 0.97, 95%CI: 0.94–0.99; insufficient sleep: β = 0.96, 95%CI: 0.93–0.99).The results of ORs (95%CIs) per 1-SD increase supported above findings in the same model (OSA: OR = 0.92, 95%CI: 0.80–0.99; day sleepiness: OR = 0.88, 95%CI: 0.79–0.98; insufficient sleep: OR = 0.85, 95%CI: 0.76–0.96). Additionally, RCS displayed non-linear relationship between CDAI and the risk of OSA (p for non-linearity < 0.001) (Fig. 2(A)) and day sleepiness (p for non-linearity < 0.001) (Fig. 2(B)), suggesting plateaued associations at the higher CDAI exposure range. However, linear inverse correlation was found between CDAI and insufficient sleep risk (p for non-linearity = 0.172) (Fig. 2(C)).
Table 2
Weighted logistic regression analyses of CDAI with three sleep-related outcomes
Variables
Model 1
Model 2
Model 3
OR (95%CI)
P
OR (95%CI)
P
OR (95%CI)
P
OSA
      
CDAI
0.99(0.97,1.00)
0.063
0.98(0.97,1.00)
0.018
0.98(0.95,1.00)
0.041
CDAI
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.87(0.72,1.06)
0.170
0.84(0.68,1.03)
0.091
0.81(0.63,1.05)
0.101
Q3
0.85(0.69,1.04)
0.113
0.79(0.64,0.98)
0.033
0.74(0.54,1.01)
0.058
Q4
0.81(0.66,0.98)
0.042
0.75(0.60,0.94)
0.014
0.69(0.49,0.97)
0.035
P for trend
 
0.041
 
0.012
 
0.029
Per 1-SD increase
0.94(0.89,1.00)
0.063
0.92(0.87,0.98)
0.018
0.92(0.80,0.99)
0.041
Day sleepiness
      
CDAI
0.98(0.95,1.01)
0.111
0.98(0.95,1.00)
0.078
0.97(0.94,0.99)
0.027
CDAI
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.75(0.57,0.97)
0.028
0.78(0.60,1.01)
0.060
0.75(0.54,1.03)
0.070
Q3
0.83(0.64,1.08)
0.163
0.86(0.66,1.13)
0.274
0.81(0.59,1.12)
0.164
Q4
0.71(0.51,0.98)
0.038
0.72(0.52,0.98)
0.036
0.64(0.44,0.94)
0.029
P for trend
 
0.075
 
0.068
 
0.034
Per 1-SD increase
0.91(0.82,1.02)
0.111
0.91(0.82,1.01)
0.078
0.88(0.79,0.98)
0.027
Insufficient Sleep
      
CDAI
0.96(0.94,0.97)
< 0.001
0.96(0.94,0.98)
< 0.001
0.96(0.93,0.99)
0.013
CDAI
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.91(0.77,1.09)
0.292
0.92(0.77,1.10)
0.330
0.95(0.75,1.20)
0.609
Q3
0.78(0.65,0.95)
0.013
0.79(0.66,0.96)
0.020
0.82(0.64,1.07)
0.121
Q4
0.62(0.51,0.76)
< 0.001
0.64(0.52,0.79)
< 0.001
0.68(0.50,0.92)
0.021
P for trend
 
< 0.001
 
< 0.001
 
0.014
Per 1-SD increase
0.83(0.77,0.90)
< 0.001
0.84(0.78,0.92)
< 0.001
0.85(0.76,0.96)
0.013
Model 1: None
Model 2: Age, gender, race, marital status;
Model 3: Age, gender, race, marital status, education, PIR, BMI, smoke, alcohol status, CVD, hypertension, diabetes status, energy intakes, caffeine, carbohydrate, fat, protein, and fiber
Abbreviations: OSA, Obstructive sleep apnea; CDAI, composite dietary antioxidant index; PIR, poverty income ratio; BMI, body mass index; CVD, cardiovascular disease; OR, odds ratio; CI, confidence interval; Q, quartile; SD, standard deviation

Individual antioxidant component and sleep-related outcomes

A correlation between specific antioxidant constituent and each sleep-related outcome was assessed by dividing the value of individual antioxidant into quartiles, with the first quartile (Q1) selected as the reference category. Detailed results are showed in Table 3. For OSA, after adjusting all confounding factors, the OR (95%CI) comparing the highest quartile (Q4) with the first quartile (Q1) was 0.69 (0.50–0.96, p for trend = 0.029) for vitamin A, 0.75 (0.57–0.97, p for trend = 0.035) for vitamin C and 0.81 (0.65–0.98, p for trend = 0.036) for carotenoids, respectively. However, these inverse correlations were only found in vitamin E and vitamin C on day sleepiness risk. When comparing with lowest quartile (Q1), the highest quartile (Q4) of vitamin E and vitamin C were both associated with lower day sleepiness in the same fully-adjusted model with the corresponding ORs (95%CIs) were 0.70 (0.53–0.92, p for trend = 0.012) and 0.64 (0.49–0.84, p for trend = 0.020). In addition, we found vitamin A, selenium and carotenoids in the highest quartile (Q4) comparing with the lowest quartile (Q1) were all associated with lower insufficient sleep with the corresponding OR (95%CI) was 0.72 (0.52–0.99, p for trend = 0.036), 0.78 (0.62–0.96, p for trend = 0.035) and 0.77 (0.60–0.98, p for trend = 0.034), respectively. By contrast, these negative associations were not showed in other antioxidants.
Table 3
*Multivariable-adjusted logistic regressions for three sleep outcomes according to daily intakes of individual antioxidant components
Variables
OSA
Day sleepiness
Insufficient Sleep
OR (95%CI)
P
OR (95%CI)
P
OR (95%CI)
P
Vitamin A,mcg/day
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.77(0.58,1.03)
0.069
0.93(0.73,1.19)
0.497
0.82(0.63,1.06)
0.114
Q3
0.71(0.54,0.94)
0.023
0.92(0.70,1.23)
0.535
0.75(0.58,0.98)
0.036
Q4
0.69(0.50,0.96)
0.034
0.89(0.66,1.21)
0.402
0.72(0.52,0.99)
0.041
P for trend
 
0.029
 
0.450
 
0.036
Vitamin E,mg/day
      
Q1
Reference
 
Reference
 
Reference
 
Q2
1.02(0.76,1.38)
0.865
0.80(0.61,1.04)
0.088
0.97(0.75,1.26)
0.795
Q3
1.03(0.76,1.40)
0.825
0.79(0.62,1.01)
0.055
0.91(0.71,1.16)
0.378
Q4
1.08(0.81,1.42)
0.556
0.70(0.53,0.92)
0.018
0.86(0.68,1.09)
0.169
P for trend
 
0.562
 
0.012
 
0.122
Vitamin C,mg/day
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.85(0.62,1.17)
0.277
0.80(0.60,1.05)
0.096
0.86(0.62,1.19)
0.304
Q3
0.78(0.58,1.05)
0.088
0.78(0.60,1.02)
0.066
0.84(0.63,1.10)
0.172
Q4
0.75(0.57,0.97)
0.035
0.64(0.49,0.84)
0.006
0.85(0.65,1.10)
0.170
P for trend
 
0.020
 
0.020
 
0.119
ZinC,mg/day
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.95(0.71,1.27)
0.686
0.91(0.67,1.23)
0.479
0.92(0.74,1.22)
0.524
Q3
0.82(0.61,1.10)
0.160
0.92(0.70,1.21)
0.494
0.78(0.60,0.99)
0.047
Q4
0.87(0.61,1.24)
0.373
0.89(0.61,1.30)
0.485
0.80(0.69,1.3)
0.281
P for trend
 
0.244
 
0.520
 
0.300
Selenium,mcg/day
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.95(0.74,1.22)
0.641
0.98(0.71,1.34)
0.859
0.72(0.57,0.94)
0.023
Q3
0.95(0.65,1.37)
0.730
0.78(0.55,1.12)
0.147
0.75(0.60,0.95)
0.028
Q4
1.01(0.64,1.59)
0.963
0.96(0.56,1.64)
0.853
0.78(0.62,0.96)
0.034
P for trend
 
0.480
 
0.472
 
0.035
Carotenoids,mcg/day
      
Q1
Reference
 
Reference
 
Reference
 
Q2
0.91(0.72,1.15)
0.370
0.84(0.63,1.12)
0.196
0.87(0.73,1.04)
0.100
Q3
0.90(0.69,1.17)
0.386
0.84(0.67,1.05)
0.107
0.93(0.75,1.16)
0.463
Q4
0.81(0.65,0.98)
0.036
0.81(0.63,1.05)
0.101
0.77(0.60,0.98)
0.034
P for trend
 
0.036
 
0.102
 
0.042
*Adjusted for age, gender, race, marital status, education, PIR, BMI, smoke, alcohol status, CVD, hypertension, diabetes status, energy intakes, caffeine, carbohydrate, fat, protein, and fiber

Subgroup analysis

In order to examine whether the correlation between CDAI and each sleep-related outcome was robust in different population stratified by age, gender, hypertension, diabetes status, BMI, race and PIR, subgroup analyses were performed (Fig. 3). The results indicated that relatively stronger associations between CDAI and sleep outcomes were consistently found among young adults (age < 60 years), males, adults without hypertension and diabetes, the White and PIR > 3.50. No significant interactions of CDAI with these stratified variables were observed (all p for interaction > 0.050).

Discussion

In this large-scale study of 7274 Americans from NHANES, we discovered that CDAI was non-linearly associated with lower risk of OSA and day sleepiness. At the same time, a linear inverse association between CDAI and insufficient sleep was observed. These findings highlighted the protective effect of antioxidative dietary and provided clinical evidence for the beneficial sleep health from increasing intake of dietary antioxidants.
To date, numerous epidemiological investigations have explored the efficacy of single antioxidant on sleep health, while few studies have focused on the effect of DTAC on sleep disorders. Kanagasabai et al. found that individuals with adequate sleep duration generally had an ideal level of serum vitamin C and other antioxidants profiles in comparison to short or very short sleeper [24]. Observational studies of vitamin A and sleep health are extremely limited and controversial. Natsuko et at. performed a questionnaire survey composed of 3304 Japanese female students and observed that the level of vitamin A intake was linked to disturbed wake–sleep cycle [25], whereas another study discovered there was no significant difference in serum vitamin A levels among adolescent girls with sleepiness comparing with control groups [26]. Although vitamin E was regarded as an important antioxidant, previous studies on vitamin E and sleep have also been controversial. Increased intake of vitamin E was associated with longer sleep time [27] and might reduce memory damage during chronic sleep deprivation [28]. In contrast, a randomized and stratified epidemiological study including 169 mild OSA patients and 83 moderate/severe OSA patients demonstrated that intake of vitamin A, C, D and E was not linked to OSA severity [29]. Interestingly, existing evidence from different observational research consistently supported that carotenoid consumption positively associated with sleep quality, which directly supported our findings in current study. For instance, Stringham et al. showed that healthy adults who were supplemented with 24 mg of macular carotenoid per day experienced improvements in sleep quality [30]. Furthermore, a NHANES 2005–2006 study also found that lower level of serum carotenoid concentration was associated with shorter sleep duration [31]. Despite all this, few studies have evaluated the interaction among different dietary antioxidants on sleep problems. A prior cross-sectional study of 265 diabetic women demonstrated that DTAC was inversely associated with poor sleep quality [11]. Similarly, another cross-sectional study conducted among Iranian post-menopausal women revealed that DTAC was inversely related to sleep disorders and other symptoms related menopause [12].
In present study, we utilized CDAI to comprehensively assess interactive effect of the antioxidants, which was an effective and promising strategy. Our results are generally reasonable. First, oxidative stress constitutes a critical hallmark of sleep disorders. A previous system review indicated that insufficient sleep could activate stress-related neurobiological mechanisms and trigger oxidative processes [32]. An increasing number of epidemiological evidence underlined the adverse effects of oxidative stress in patients with OSA, including the elevated level of intracellular reactive oxygen species (ROS) [33] and decreased level of nitric oxide (NO) or its derivatives [34, 35]. As a matter of fact, unlike other cells, the brain neurons are particularly vulnerable to oxidative stress since they tend to have higher metabolic demands and lower endogenous antioxidant levels [36]. Given that oxidative stress can aggravate impairment to the brain, contributing to the reduction of neurotransmitter concentrations and further affecting sleep quality [37], it is highly plausible that adequate antioxidant dietary may lower the risk of OSA and insufficient sleep via their powerful antioxidant properties.
Second, high-grade inflammation has been acted as a crucial role in the development of OSA [38, 39]. In fact, a prior meta-analysis has demonstrated that sleep disorders and insufficient sleep have elevated levels of c-reactive protein (CRP) and interleukin-6 (IL-6) [24, 40]. A study included three prospective US cohorts suggested that higher anti-inflammatory diet was related to a lower systemic inflammation among 8856 OSA participants [41]. So far, some researchers have verified a negative correlation between DTAC and serum CRP, involving the nuclear transcription factor-κB (NF-κB) pathway [37, 42]. Moreover, two Italian studies based on a two-week intervention with a high DTAC lead to lower CRP levels [43, 44]. Likewise, a population-based cohort study of 3853 Chinese women demonstrated that CDAI was inversely associated with levels of interleukin-1beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) [45]. In addition, participants with higher CDAI in our study may consume more vitamins, vegetables and fruits and further display their protective benefits.
Third, glucose metabolism imbalance has been considered as a key risk factor of OSA as well as sleep disorders. A system review suggested that poorly controlled glucose levels could aggravate OSA by impacting central control of respiration and upper airway neural reflexes [37].To some extent, sufficient consumption of antioxidants has associated with lower glucose concentration [46] and improved pancreatic β-cell function [47]. A cohort study of 2694 older people aged more than 59 years old found that higher DTAC was linked to better glucose tolerance [48]. Similar results were found in younger [42] and middle-aged adults [49]. Furthermore, high intake of antioxidants from foods and beverages might provide dietary fiber, magnesium and some enzymes, which were important modifiers in glucose metabolism [50, 51]. Thus, a higher CDAI is related to more intake of these individual antioxidant nutrient, which have beneficial influence on our sleep health.
It is highlighted that non-linear associations between CDAI and the risk of OSA and day sleepiness were found in current study, suggesting the odds of OSA and day sleepiness decreased with the increase of CDAI in a certain range. However, the underlying mechanism of this non-linear relationship still remain unclear. Previous researches reported that dietary zinc and selenium had both properties of antioxidant and prooxidant, which could cause oxidative stress and lose antioxidant capacity when they were out of certain range [52, 53]. Dietary selenium has been linked to increased activation of white blood cells, proliferation and differentiation of immune cells, as well as the production of interferon γ (IFN γ) and other cytokines [54, 55]. Additionally, selenium exerts antioxidant, immunomodulatory and anti-inflammatory effects through the selenoproteins such as selenium-dependent glutathione peroxidase (GPx) [56]. However, an increase in GPx1 activity can potentially disrupt insulin function by excessively suppressing intracellular ROS required for insulin sensitization, ultimately leading to hyperglycemia [57]. Moreover, a meta-analysis of 5 randomized controlled trials has indicated that although selenium administration may improve insulin sensitivity to some extent, no positive effects on lipid profiles or glucose homeostasis have been observed [58]. Thirdly, it is noteworthy that a high dietary antioxidant index is not solely determined by an increased intake of dietary antioxidants, but is also influenced by the consumption of pro-oxidant foods. For instance, red meat, sugary foods, and starches can have pro-oxidant effects due to their high content of advanced glycation end products (AGEs), which are formed during cooking and processing [59]. AGEs can activate inflammatory pathways and generate ROS, which can damage cells and tissues in that counteract the positive effects of antioxidants on the body [60, 61]. These findings offer insight into the antioxidant paradox from various perspectives. Thus, it is possible that excessive intake of zinc and selenium may modify the protective effect of vitamins and carotenoids. More investigations are needed to confirm these dose-response relationship and understand these biological mechanisms.

Strength and limitations

Our study has several noteworthy advantages. First of all, our study data is based on NHANES, which provides a large-scale and nationally representative database, making our study findings reliable. Second, we further determine a promising and comprehensive index for OSA patients by dietary intervention, which fully consider the potential interactions between different antioxidant nutrients. However, some limitations should be noted. First, information about dietary intake was obtained only at baseline without dynamic follow-up. Moreover, two 24-hour recall dietary interviews are limitations regarding correlations between antioxidants and sleep disorders because blood levels of antioxidants would be preferable. Second, the diagnosis of OSA was used by face-to-face interview but not respiratory sleep monitoring, which was a gold standard in clinical practice. Third, given the nature of cross-sectional design, these causal associations cannot be ensured, so more prospective and well-designed studies are urgent to conduct in the future. Finally, although some conventional variables were fully controlled in current study, other measured confounders were not considered.

Conclusion

In summary, the present research indicated that CDAI was non-linearly associated with lower risk of OSA and day sleepiness whereas a linear inverse association between CDAI and insufficient sleep was observed. These findings implicated that combined intake of antioxidants could be a promising and effective approach to optimize sleep quality for public. Further large-scale research is urgent to demonstrate these associations and biological mechanisms.

Acknowledgements

We thank Zhang Jing for his excellent contribution to the NHANES database so that we can easily extract these data.

Declarations

Ethics statement

The studies involving participants provided informed consent forms when they were enrolled. There is no need to provide additional local ethical approval due to the data’s openness and originality.
Not applicable.

Competing interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Deng M-G, Nie J-Q, Li Y-Y, Yu X, Zhang Z-J, Higher. HEI-2015 scores are Associated with Lower Risk of Sleep Disorder: results from a nationally Representative Survey of United States adults. Nutrients. 2022;14:873.PubMedPubMedCentralCrossRef Deng M-G, Nie J-Q, Li Y-Y, Yu X, Zhang Z-J, Higher. HEI-2015 scores are Associated with Lower Risk of Sleep Disorder: results from a nationally Representative Survey of United States adults. Nutrients. 2022;14:873.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45:43.PubMedPubMedCentralCrossRef Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45:43.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5:173–8.PubMedPubMedCentralCrossRef Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5:173–8.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Zheng Y, Zhang L, Bonfili L, de Vivo L, Eleuteri AM, Bellesi M. Probiotics Supplementation attenuates inflammation and oxidative stress Induced by Chronic Sleep Restriction. Nutrients. 2023;15:1518.PubMedPubMedCentralCrossRef Zheng Y, Zhang L, Bonfili L, de Vivo L, Eleuteri AM, Bellesi M. Probiotics Supplementation attenuates inflammation and oxidative stress Induced by Chronic Sleep Restriction. Nutrients. 2023;15:1518.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Gasmi A, Semenova Y, Noor S, Benahmed AG, Bjørklund G. Sleep, dietary melatonin supplementation, and COVID-19. Curr Med Chem. 2023;31:1298–314. Gasmi A, Semenova Y, Noor S, Benahmed AG, Bjørklund G. Sleep, dietary melatonin supplementation, and COVID-19. Curr Med Chem. 2023;31:1298–314.
7.
Zurück zum Zitat Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR et al. Melatonin and health: insights of Melatonin Action, Biological functions, and Associated disorders. Cell Mol Neurobiol. 2023;:1–22. Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR et al. Melatonin and health: insights of Melatonin Action, Biological functions, and Associated disorders. Cell Mol Neurobiol. 2023;:1–22.
9.
Zurück zum Zitat Sheng L-T, Jiang Y-W, Pan A, Koh W-P. Dietary total antioxidant capacity and mortality outcomes: the Singapore Chinese Health Study. Eur J Nutr. 2022;61:2375–82.PubMedCrossRef Sheng L-T, Jiang Y-W, Pan A, Koh W-P. Dietary total antioxidant capacity and mortality outcomes: the Singapore Chinese Health Study. Eur J Nutr. 2022;61:2375–82.PubMedCrossRef
10.
Zurück zum Zitat Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–57.PubMedCrossRef Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–57.PubMedCrossRef
11.
Zurück zum Zitat Daneshzad E, Keshavarz S-A, Qorbani M, Larijani B, Azadbakht L. Dietary total antioxidant capacity and its association with sleep, stress, anxiety, and depression score: a cross-sectional study among diabetic women. Clin Nutr ESPEN. 2020;37:187–94.PubMedCrossRef Daneshzad E, Keshavarz S-A, Qorbani M, Larijani B, Azadbakht L. Dietary total antioxidant capacity and its association with sleep, stress, anxiety, and depression score: a cross-sectional study among diabetic women. Clin Nutr ESPEN. 2020;37:187–94.PubMedCrossRef
12.
Zurück zum Zitat Abshirini M, Siassi F, Koohdani F, Qorbani M, Khosravi S, Hedayati M, et al. Dietary total antioxidant capacity is inversely related to menopausal symptoms: a cross-sectional study among Iranian postmenopausal women. Nutrition. 2018;55–56:161–7.PubMedCrossRef Abshirini M, Siassi F, Koohdani F, Qorbani M, Khosravi S, Hedayati M, et al. Dietary total antioxidant capacity is inversely related to menopausal symptoms: a cross-sectional study among Iranian postmenopausal women. Nutrition. 2018;55–56:161–7.PubMedCrossRef
13.
Zurück zum Zitat Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. 2013;1:1–37. Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. 2013;1:1–37.
14.
Zurück zum Zitat Borrud L, Chiappa MM, Burt VL, Gahche J, Zipf G, Johnson CL et al. National Health and Nutrition Examination Survey: national youth fitness survey plan, operations, and analysis, 2012. Vital Health Stat 2. 2014;:1–24. Borrud L, Chiappa MM, Burt VL, Gahche J, Zipf G, Johnson CL et al. National Health and Nutrition Examination Survey: national youth fitness survey plan, operations, and analysis, 2012. Vital Health Stat 2. 2014;:1–24.
16.
17.
Zurück zum Zitat Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1:40–3.PubMedCrossRef Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1:40–3.PubMedCrossRef
18.
19.
Zurück zum Zitat Zhang HR, Yang Y, Tian W, Sun YJ. Dietary Fiber and all-cause and Cardiovascular Mortality in older adults with hypertension: a cohort study of NHANES. J Nutr Health Aging. 2022;26:407–14.PubMedCrossRef Zhang HR, Yang Y, Tian W, Sun YJ. Dietary Fiber and all-cause and Cardiovascular Mortality in older adults with hypertension: a cohort study of NHANES. J Nutr Health Aging. 2022;26:407–14.PubMedCrossRef
20.
Zurück zum Zitat Maugeri A, Hruskova J, Jakubik J, Kunzova S, Sochor O, Barchitta M, et al. Dietary antioxidant intake decreases carotid intima media thickness in women but not in men: a cross-sectional assessment in the Kardiovize study. Free Radic Biol Med. 2019;131:274–81.PubMedCrossRef Maugeri A, Hruskova J, Jakubik J, Kunzova S, Sochor O, Barchitta M, et al. Dietary antioxidant intake decreases carotid intima media thickness in women but not in men: a cross-sectional assessment in the Kardiovize study. Free Radic Biol Med. 2019;131:274–81.PubMedCrossRef
21.
Zurück zum Zitat Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, et al. Inverse Association of Telomere length with Liver Disease and Mortality in the US Population. Hepatol Commun. 2022;6:399–410.PubMedCrossRef Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, et al. Inverse Association of Telomere length with Liver Disease and Mortality in the US Population. Hepatol Commun. 2022;6:399–410.PubMedCrossRef
22.
Zurück zum Zitat Lloyd-Jones DM, Ning H, Labarthe D, Brewer L, Sharma G, Rosamond W, et al. Status of Cardiovascular Health in US adults and Children Using the American Heart Association’s New Life’s essential 8 Metrics: Prevalence Estimates from the National Health and Nutrition Examination Survey (NHANES), 2013 through 2018. Circulation. 2022;146:822–35.PubMedCrossRef Lloyd-Jones DM, Ning H, Labarthe D, Brewer L, Sharma G, Rosamond W, et al. Status of Cardiovascular Health in US adults and Children Using the American Heart Association’s New Life’s essential 8 Metrics: Prevalence Estimates from the National Health and Nutrition Examination Survey (NHANES), 2013 through 2018. Circulation. 2022;146:822–35.PubMedCrossRef
23.
Zurück zum Zitat Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65 4 Suppl:1220S-1228S; discussion 1229S-1231S. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65 4 Suppl:1220S-1228S; discussion 1229S-1231S.
24.
Zurück zum Zitat Kanagasabai T, Ardern CI. Contribution of inflammation, oxidative stress, and antioxidants to the relationship between Sleep Duration and Cardiometabolic Health. Sleep. 2015;38:1905–12.PubMedPubMedCentralCrossRef Kanagasabai T, Ardern CI. Contribution of inflammation, oxidative stress, and antioxidants to the relationship between Sleep Duration and Cardiometabolic Health. Sleep. 2015;38:1905–12.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Sato-Mito N, Sasaki S, Murakami K, Okubo H, Takahashi Y, Shibata S, et al. The midpoint of sleep is associated with dietary intake and dietary behavior among young Japanese women. Sleep Med. 2011;12:289–94.PubMedCrossRef Sato-Mito N, Sasaki S, Murakami K, Okubo H, Takahashi Y, Shibata S, et al. The midpoint of sleep is associated with dietary intake and dietary behavior among young Japanese women. Sleep Med. 2011;12:289–94.PubMedCrossRef
26.
Zurück zum Zitat Bahrami A, Khorasanchi Z, Sadeghnia HR, Tayefi M, Avan A, Ferns GA, et al. Depression in adolescent girls: relationship to serum vitamins a and E, immune response to heat shock protein 27 and systemic inflammation. J Affect Disord. 2019;252:68–73.PubMedCrossRef Bahrami A, Khorasanchi Z, Sadeghnia HR, Tayefi M, Avan A, Ferns GA, et al. Depression in adolescent girls: relationship to serum vitamins a and E, immune response to heat shock protein 27 and systemic inflammation. J Affect Disord. 2019;252:68–73.PubMedCrossRef
27.
Zurück zum Zitat Grandner MA, Kripke DF, Naidoo N, Langer RD. Relationships among dietary nutrients and subjective sleep, objective sleep, and napping in women. Sleep Med. 2010;11:180–4.PubMedCrossRef Grandner MA, Kripke DF, Naidoo N, Langer RD. Relationships among dietary nutrients and subjective sleep, objective sleep, and napping in women. Sleep Med. 2010;11:180–4.PubMedCrossRef
28.
Zurück zum Zitat Alzoubi KH, Khabour OF, Rashid BA, Damaj IM, Salah HA. The neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress. Behav Brain Res. 2012;226:205–10.PubMedCrossRef Alzoubi KH, Khabour OF, Rashid BA, Damaj IM, Salah HA. The neuroprotective effect of vitamin E on chronic sleep deprivation-induced memory impairment: the role of oxidative stress. Behav Brain Res. 2012;226:205–10.PubMedCrossRef
29.
Zurück zum Zitat Chrysostomou S, Frangopoulos F, Koutras Y, Andreou K, Socratous L, Giannakou K. The relation of dietary components with severity of obstructive sleep apnea in Cypriot patients: a randomized, stratified epidemiological study. PLoS ONE. 2022;17:e0265148.PubMedPubMedCentralCrossRef Chrysostomou S, Frangopoulos F, Koutras Y, Andreou K, Socratous L, Giannakou K. The relation of dietary components with severity of obstructive sleep apnea in Cypriot patients: a randomized, stratified epidemiological study. PLoS ONE. 2022;17:e0265148.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Stringham JM, Stringham NT, O’Brien KJ. Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and adverse physical symptoms in those with high screen time exposure. Foods. 2017;6:47.PubMedPubMedCentralCrossRef Stringham JM, Stringham NT, O’Brien KJ. Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and adverse physical symptoms in those with high screen time exposure. Foods. 2017;6:47.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Beydoun MA, Gamaldo AA, Canas JA, Beydoun HA, Shah MT, McNeely JM, et al. Serum nutritional biomarkers and their associations with sleep among US adults in recent national surveys. PLoS ONE. 2014;9:e103490.ADSPubMedPubMedCentralCrossRef Beydoun MA, Gamaldo AA, Canas JA, Beydoun HA, Shah MT, McNeely JM, et al. Serum nutritional biomarkers and their associations with sleep among US adults in recent national surveys. PLoS ONE. 2014;9:e103490.ADSPubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Villafuerte G, Miguel-Puga A, Rodríguez EM, Machado S, Manjarrez E, Arias-Carrión O. Sleep deprivation and oxidative stress in animal models: a systematic review. Oxid Med Cell Longev. 2015;2015:234952.PubMedPubMedCentralCrossRef Villafuerte G, Miguel-Puga A, Rodríguez EM, Machado S, Manjarrez E, Arias-Carrión O. Sleep deprivation and oxidative stress in animal models: a systematic review. Oxid Med Cell Longev. 2015;2015:234952.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165:934–9.PubMedCrossRef Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165:934–9.PubMedCrossRef
34.
Zurück zum Zitat Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax. 2000;55:1046–51.PubMedPubMedCentralCrossRef Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lücke C, Mayer K, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax. 2000;55:1046–51.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162:2166–71.PubMedCrossRef Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med. 2000;162:2166–71.PubMedCrossRef
36.
Zurück zum Zitat Lehtinen MK, Bonni A. Modeling oxidative stress in the central nervous system. Curr Mol Med. 2006;6:871–81.PubMedCrossRef Lehtinen MK, Bonni A. Modeling oxidative stress in the central nervous system. Curr Mol Med. 2006;6:871–81.PubMedCrossRef
40.
Zurück zum Zitat Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, Sleep Duration, and inflammation: a systematic review and Meta-analysis of Cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80:40–52.PubMedCrossRef Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, Sleep Duration, and inflammation: a systematic review and Meta-analysis of Cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80:40–52.PubMedCrossRef
41.
Zurück zum Zitat Liu Y, Tabung FK, Stampfer MJ, Redline S, Huang T. Overall diet quality and proinflammatory diet in relation to risk of obstructive sleep apnea in 3 prospective US cohorts. Am J Clin Nutr. 2022;116:1738–47.PubMedPubMedCentralCrossRef Liu Y, Tabung FK, Stampfer MJ, Redline S, Huang T. Overall diet quality and proinflammatory diet in relation to risk of obstructive sleep apnea in 3 prospective US cohorts. Am J Clin Nutr. 2022;116:1738–47.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Hermsdorff HHM, Puchau B, Volp ACP, Barbosa KB, Bressan J, Zulet MÁ, et al. Dietary total antioxidant capacity is inversely related to central adiposity as well as to metabolic and oxidative stress markers in healthy young adults. Nutr Metab (Lond). 2011;8:59.PubMedCrossRef Hermsdorff HHM, Puchau B, Volp ACP, Barbosa KB, Bressan J, Zulet MÁ, et al. Dietary total antioxidant capacity is inversely related to central adiposity as well as to metabolic and oxidative stress markers in healthy young adults. Nutr Metab (Lond). 2011;8:59.PubMedCrossRef
43.
Zurück zum Zitat Valtueña S, Pellegrini N, Franzini L, Bianchi MA, Ardigò D, Del Rio D, et al. Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr. 2008;87:1290–7.PubMedCrossRef Valtueña S, Pellegrini N, Franzini L, Bianchi MA, Ardigò D, Del Rio D, et al. Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr. 2008;87:1290–7.PubMedCrossRef
44.
Zurück zum Zitat Franzini L, Ardigò D, Valtueña S, Pellegrini N, Del Rio D, Bianchi MA, et al. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012;22:50–7.PubMedCrossRef Franzini L, Ardigò D, Valtueña S, Pellegrini N, Del Rio D, Bianchi MA, et al. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis. 2012;22:50–7.PubMedCrossRef
45.
Zurück zum Zitat Luu HN, Wen W, Li H, Dai Q, Yang G, Cai Q, et al. Are dietary antioxidant intake indices correlated to oxidative stress and inflammatory marker levels? Antioxid Redox Signal. 2015;22:951–9.PubMedPubMedCentralCrossRef Luu HN, Wen W, Li H, Dai Q, Yang G, Cai Q, et al. Are dietary antioxidant intake indices correlated to oxidative stress and inflammatory marker levels? Antioxid Redox Signal. 2015;22:951–9.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Yao LH, Jiang YM, Shi J, Tomás-Barberán FA, Datta N, Singanusong R, et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr. 2004;59:113–22.PubMedCrossRef Yao LH, Jiang YM, Shi J, Tomás-Barberán FA, Datta N, Singanusong R, et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr. 2004;59:113–22.PubMedCrossRef
47.
Zurück zum Zitat Sotoudeh G, Abshirini M, Bagheri F, Siassi F, Koohdani F, Aslany Z. Higher dietary total antioxidant capacity is inversely related to prediabetes: a case-control study. Nutrition. 2018;46:20–5.PubMedCrossRef Sotoudeh G, Abshirini M, Bagheri F, Siassi F, Koohdani F, Aslany Z. Higher dietary total antioxidant capacity is inversely related to prediabetes: a case-control study. Nutrition. 2018;46:20–5.PubMedCrossRef
48.
Zurück zum Zitat Okubo H, Syddall HE, Phillips DIW, Sayer AA, Dennison EM, Cooper C, et al. Dietary total antioxidant capacity is related to glucose tolerance in older people: the Hertfordshire Cohort Study. Nutr Metab Cardiovasc Dis. 2014;24:301–8.PubMedCrossRef Okubo H, Syddall HE, Phillips DIW, Sayer AA, Dennison EM, Cooper C, et al. Dietary total antioxidant capacity is related to glucose tolerance in older people: the Hertfordshire Cohort Study. Nutr Metab Cardiovasc Dis. 2014;24:301–8.PubMedCrossRef
49.
Zurück zum Zitat Psaltopoulou T, Panagiotakos DB, Pitsavos C, Chrysochoou C, Detopoulou P, Skoumas J, et al. Dietary antioxidant capacity is inversely associated with diabetes biomarkers: the ATTICA study. Nutr Metab Cardiovasc Dis. 2011;21:561–7.PubMedCrossRef Psaltopoulou T, Panagiotakos DB, Pitsavos C, Chrysochoou C, Detopoulou P, Skoumas J, et al. Dietary antioxidant capacity is inversely associated with diabetes biomarkers: the ATTICA study. Nutr Metab Cardiovasc Dis. 2011;21:561–7.PubMedCrossRef
50.
Zurück zum Zitat Ford ES, Mokdad AH. Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults. Prev Med. 2001;32:33–9.PubMedCrossRef Ford ES, Mokdad AH. Fruit and vegetable consumption and diabetes mellitus incidence among U.S. adults. Prev Med. 2001;32:33–9.PubMedCrossRef
51.
Zurück zum Zitat Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.PubMedCrossRef Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.PubMedCrossRef
52.
Zurück zum Zitat Lee KH, Jeong D. Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: the selenium paradox (review). Mol Med Rep. 2012;5:299–304.PubMed Lee KH, Jeong D. Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: the selenium paradox (review). Mol Med Rep. 2012;5:299–304.PubMed
53.
Zurück zum Zitat Yuan Y, Niu F, Liu Y, Lu N. Zinc and its effects on oxidative stress in Alzheimer’s disease. Neurol Sci. 2014;35:923–8.PubMedCrossRef Yuan Y, Niu F, Liu Y, Lu N. Zinc and its effects on oxidative stress in Alzheimer’s disease. Neurol Sci. 2014;35:923–8.PubMedCrossRef
54.
Zurück zum Zitat Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci. 2022;23:3636.PubMedPubMedCentralCrossRef Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci. 2022;23:3636.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Bentley-Hewitt KL, Chen RK-Y, Lill RE, Hedderley DI, Herath TD, Matich AJ, et al. Consumption of selenium-enriched broccoli increases cytokine production in human peripheral blood mononuclear cells stimulated ex vivo, a preliminary human intervention study. Mol Nutr Food Res. 2014;58:2350–7.PubMedCrossRef Bentley-Hewitt KL, Chen RK-Y, Lill RE, Hedderley DI, Herath TD, Matich AJ, et al. Consumption of selenium-enriched broccoli increases cytokine production in human peripheral blood mononuclear cells stimulated ex vivo, a preliminary human intervention study. Mol Nutr Food Res. 2014;58:2350–7.PubMedCrossRef
56.
Zurück zum Zitat Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–90.ADSPubMedCrossRef Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–90.ADSPubMedCrossRef
57.
Zurück zum Zitat McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, et al. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A. 2004;101:8852–7.ADSPubMedPubMedCentralCrossRef McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, et al. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A. 2004;101:8852–7.ADSPubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Tabrizi R, Akbari M, Moosazadeh M, Lankarani KB, Heydari ST, Kolahdooz F, et al. The effects of Selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and Meta-analysis of Randomized controlled trials. Horm Metab Res. 2017;49:826–30.PubMedCrossRef Tabrizi R, Akbari M, Moosazadeh M, Lankarani KB, Heydari ST, Kolahdooz F, et al. The effects of Selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: a systematic review and Meta-analysis of Randomized controlled trials. Horm Metab Res. 2017;49:826–30.PubMedCrossRef
59.
Zurück zum Zitat Nowotny K, Schröter D, Schreiner M, Grune T. Dietary advanced glycation end products and their relevance for human health. Ageing Res Rev. 2018;47:55–66.PubMedCrossRef Nowotny K, Schröter D, Schreiner M, Grune T. Dietary advanced glycation end products and their relevance for human health. Ageing Res Rev. 2018;47:55–66.PubMedCrossRef
60.
Zurück zum Zitat Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol Biol Sci Med Sci. 2007;62:427–33.CrossRef Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol Biol Sci Med Sci. 2007;62:427–33.CrossRef
61.
Zurück zum Zitat Byun K, Yoo Y, Son M, Lee J, Jeong G-B, Park YM, et al. Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases. Pharmacol Ther. 2017;177:44–55.PubMedCrossRef Byun K, Yoo Y, Son M, Lee J, Jeong G-B, Park YM, et al. Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases. Pharmacol Ther. 2017;177:44–55.PubMedCrossRef
Metadaten
Titel
Composite dietary antioxidant index and sleep health: a new insight from cross-sectional study
verfasst von
Bingquan Xiong
Jiaxin Wang
Rui He
Guangsu Qu
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2024
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18047-2

Weitere Artikel der Ausgabe 1/2024

BMC Public Health 1/2024 Zur Ausgabe